R. Insa

568 total citations
18 papers, 360 citations indexed

About

R. Insa is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, R. Insa has authored 18 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in R. Insa's work include Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Cerebrovascular and Carotid Artery Diseases (2 papers) and Genetic Neurodegenerative Diseases (2 papers). R. Insa is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Cerebrovascular and Carotid Artery Diseases (2 papers) and Genetic Neurodegenerative Diseases (2 papers). R. Insa collaborates with scholars based in Spain, United States and India. R. Insa's co-authors include Óscar Huertas, Salvador Ventura, Nelson Ferreira, Josep Gámez, Ricardo Sant’Anna, Jorge Matías‐Guiu, Irantzu Pallarès, J M Moltó, Maria Rosário Almeida and Pablo Gallego and has published in prestigious journals such as Nature Communications, International Journal of Molecular Sciences and British Journal of Clinical Pharmacology.

In The Last Decade

R. Insa

17 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Insa Spain 8 203 74 51 42 42 18 360
Lumeng J. Yu United States 11 160 0.8× 32 0.4× 72 1.4× 95 2.3× 19 0.5× 27 454
Lin Song China 10 198 1.0× 39 0.5× 31 0.6× 34 0.8× 14 0.3× 28 421
Shiwei Li China 13 95 0.5× 75 1.0× 61 1.2× 34 0.8× 19 0.5× 40 392
Anne M. Bakken Norway 8 114 0.6× 37 0.5× 33 0.6× 30 0.7× 39 0.9× 16 451
İlyas Okur Türkiye 12 124 0.6× 28 0.4× 136 2.7× 13 0.3× 36 0.9× 62 372
Zemou Yu China 11 119 0.6× 52 0.7× 30 0.6× 34 0.8× 17 0.4× 12 312
Jia Fu China 8 163 0.8× 42 0.6× 31 0.6× 20 0.5× 26 0.6× 19 363
Ylenia Da Valle Italy 13 102 0.5× 40 0.5× 105 2.1× 38 0.9× 9 0.2× 17 350

Countries citing papers authored by R. Insa

Since Specialization
Citations

This map shows the geographic impact of R. Insa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Insa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Insa more than expected).

Fields of papers citing papers by R. Insa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Insa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Insa. The network helps show where R. Insa may publish in the future.

Co-authorship network of co-authors of R. Insa

This figure shows the co-authorship network connecting the top 25 collaborators of R. Insa. A scholar is included among the top collaborators of R. Insa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Insa. R. Insa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Yadav, Shalini, et al.. (2024). The Impact of Medication Compliance on mild Cognitive Impairment in Hypertensive Individuals: A Cohort Study. Research Journal of Pharmacy and Technology. 5201–5209.
2.
Gámez, Josep, Matilde Calopa, Óscar Huertas, et al.. (2022). A proof‐of‐concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's disease. British Journal of Clinical Pharmacology. 89(5). 1656–1664. 5 indexed citations
3.
Jo, Seri, Suwon Kim, Mi-Sun Kim, et al.. (2022). A Study of Drug Repurposing to Identify SARS-CoV-2 Main Protease (3CLpro) Inhibitors. International Journal of Molecular Sciences. 23(12). 6468–6468. 2 indexed citations
4.
Gámez, Josep, Matilde Calopa, Esteban Muñoz, et al.. (2021). P.0426 Proof-of-concept study testing SOM3355 for the treatment of chorea symptoms in Huntington's disease. European Neuropsychopharmacology. 53. S310–S310. 1 indexed citations
5.
Suñé-Pou, Marc, Pilar Pérez‐Lozano, Montserrat Miñarro Carmona, et al.. (2020). Formulation of Sustained Release Hydrophilic Matrix Tablets of Tolcapone with the Application of Sedem Diagram: Influence of Tolcapone’s Particle Size on Sustained Release. Pharmaceutics. 12(7). 674–674. 17 indexed citations
6.
7.
Sant’Anna, Ricardo, Pablo Gallego, Nelson Ferreira, et al.. (2016). Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity. Nature Communications. 7(1). 10787–10787. 144 indexed citations
8.
Ventura, Salvador, et al.. (2015). SOM0226, a repositioned compound for the treatment of TTR amyloidosis. Orphanet Journal of Rare Diseases. 10(S1). 4 indexed citations
9.
10.
11.
Matías‐Guiu, Jorge, Francisco Bolúmar, R. Insa, et al.. (2009). Multiple sclerosis in Spain: an epidemiological study of the Alcoy health region, Valencia. Acta Neurologica Scandinavica. 81(6). 479–483. 9 indexed citations
12.
Matías‐Guiu, Jorge, et al.. (2009). Ischemic stroke in young adults. II. Analysis of risk factors in the etiological subgroups. Acta Neurologica Scandinavica. 81(4). 314–317. 6 indexed citations
13.
Ruíz-Camps, Isabel, et al.. (1999). [Insulin resistance and metabolic syndrome in first-degree relatives of patients with NIDDM].. PubMed. 112(8). 281–4. 1 indexed citations
14.
Peña‐Casanova, Jordi, I Bertran-Serra, Pilar Santacruz, et al.. (1997). [Normalization of cognitive and functional assessment instruments for dementia (NORMACODEM) (I): objectives, content and population].. PubMed. 12(2). 61–8. 33 indexed citations
15.
Insa, R., et al.. (1996). [Comparative study of nicardipine versus placebo in the prevention of cognitive deterioration in patients with transient ischemic attack].. PubMed. 23(119). 54–8. 4 indexed citations
16.
Insa, R., et al.. (1995). Effect of long-term antihypertensive therapy with angiotensin converting enzyme inhibitors on red cell sodium transport. American Journal of Hypertension. 8(6). 622–625. 7 indexed citations
17.
Moltó, J M, et al.. (1992). Cardiovascular reflexes in patients with malignant disease. Neurological Sciences. 13(2). 125–129. 21 indexed citations
18.
Matías‐Guiu, Jorge, et al.. (1989). Ischemic stroke in young adults I. Analysis of the etiological subgroups. Acta Neurologica Scandinavica. 80(1). 28–34. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lumeng J. Yu Breakdown of academic impact, for papers by Lin Song Breakdown of academic impact, for papers by Shiwei Li Breakdown of academic impact, for papers by Anne M. Bakken Breakdown of academic impact, for papers by İlyas Okur Breakdown of academic impact, for papers by Zemou Yu Breakdown of academic impact, for papers by Jia Fu Breakdown of academic impact, for papers by Ylenia Da Valle
Rankless by CCL
2026